Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Inject slowly and hold the needle in the skin for at least 6 seconds after the dose counter shows 0 to ensure complete delivery
Dosage variation allows for: Customization : Tailoring treatment to individual needs
In the phase 2 trial, 41% to 63% of participants receiving cagrilintide (0.3 to 4.5 mg) experienced gastrointestinal adverse events, compared to 32% with placebo
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients
US$ 24.21
US$ 21.23
US$ 21.89
US$ 21.51
US$ 24.80
